Bristol-Myers Squibb Company (BMY): Price and Financial Metrics
Bristol-Myers Squibb Company (BMY)
Today's Latest Price: $58.45 USD
Updated Oct 30 4:00pm
Add BMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BMY Stock Summary
- With a market capitalization of $130,547,894,059, Bristol Myers Squibb Co has a greater market value than 98.64% of US stocks.
- Bristol Myers Squibb Co's stock had its IPO on January 1, 1986, making it an older stock than 92.8% of US equities in our set.
- In terms of volatility of its share price, BMY is more volatile than merely 0.83% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Bristol Myers Squibb Co, a group of peers worth examining would be TXN, AMGN, SNY, LLY, and AZN.
- Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.
BMY Stock Price Chart Interactive Chart >
BMY Price/Volume Stats
| Current price | $58.45 | 52-week high | $68.34 |
| Prev. close | $57.92 | 52-week low | $45.76 |
| Day low | $57.59 | Volume | 11,156,016 |
| Day high | $58.48 | Avg. volume | 13,711,261 |
| 50-day MA | $60.09 | Dividend yield | 3.11% |
| 200-day MA | $60.08 | Market Cap | 132.25B |
Bristol-Myers Squibb Company (BMY) Company Bio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.
Loading social stream, please wait...